NIH launches $9.8 million neuromodulation prize
January 26, 2022
The National Institutes of Health (NIH) launched Phase 1 of the Neuromod Prize, a competition to accelerate the development of neuromodulation therapies. They are looking for novel concepts and clinical development plans for targeted treatments that adjust nerve activity to improve organ function. Submissions due April 28.